17-58756261-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014906.5(PPM1E):āc.264G>Cā(p.Glu88Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000871 in 1,549,872 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014906.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPM1E | NM_014906.5 | c.264G>C | p.Glu88Asp | missense_variant | 1/7 | ENST00000308249.4 | NP_055721.3 | |
PPM1E | NR_048561.1 | n.393G>C | non_coding_transcript_exon_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPM1E | ENST00000308249.4 | c.264G>C | p.Glu88Asp | missense_variant | 1/7 | 1 | NM_014906.5 | ENSP00000312411 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152070Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000618 AC: 9AN: 145728Hom.: 0 AF XY: 0.0000256 AC XY: 2AN XY: 78098
GnomAD4 exome AF: 0.0000901 AC: 126AN: 1397688Hom.: 0 Cov.: 34 AF XY: 0.0000813 AC XY: 56AN XY: 689218
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152184Hom.: 1 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74390
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2023 | The c.264G>C (p.E88D) alteration is located in exon 1 (coding exon 1) of the PPM1E gene. This alteration results from a G to C substitution at nucleotide position 264, causing the glutamic acid (E) at amino acid position 88 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at